Profile
Mr. Stuart Knight is a Chief Information Officer & Senior Vice President at Theravance Biopharma, Inc. Mr. Knight was previously employed as a Head-Global Markets IT & Infrastructure by Galderma Pharma SA and a Vice President-Information Technology by Ipsen Biopharmaceuticals, Inc. He received his undergraduate degree from London South Bank University.
Stuart Knight active positions
| Companies | Position | Start |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 01/11/2014 |
Former positions of Stuart Knight
| Companies | Position | End |
|---|---|---|
Galderma Pharma SA
Galderma Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company specializes in dermatological treatments and skin care products | Chief Tech/Sci/R&D Officer | 01/10/2014 |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Chief Tech/Sci/R&D Officer | 01/01/2013 |
Training of Stuart Knight
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Galderma Pharma SA
Galderma Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company specializes in dermatological treatments and skin care products | Health Technology |
London South Bank University
London South Bank University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Stuart Knight
















